Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Cloud-based Solutions for Drug Discovery, Development, and Manufacturing Market is Segmented by Service Type (Software as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS)), by Cloud Type (Public Cloud, Private Cloud, and Hybrid Cloud), by Application (Drug Discovery and Development, and Drug Manufacturing), by End User (Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others) and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cloud-based Solution for Drug Discovery Development & Manufacturing Market Size

cloud-based solutions for drug discovery, development, and manufacturing market
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 12.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cloud-based Solution for Drug Discovery Development & Manufacturing Market Analysis

The Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market is expected to register a CAGR of 12.5% during the forecast period.

As the impact of the COVID-19 pandemic grows worldwide, biotech and pharmaceutical companies, along with other healthcare organizations, have launched intensive research to learn more about the novel coronavirus. Cloud technology has been one of the most important tools for understanding and discovering the virus. The development of vaccines and drugs against it are expected to significantly impact the market. For example, according to a June 2020 article published by Ashima Gupta and Joe Corkery, Google Cloud user Schrödinger has partnered with Takeda, Novartis, Gilead Sciences, and WuXi AppTec in a charitable effort to share ideas, resources, and data to find an antiviral treatment for the coronavirus. Schrödinger, whose physics-based software platform facilitates the development of high-quality, unique compounds for therapies and materials, will use Google Cloud credits to rapidly explore and test potential new drugs under the agreement. In addition, high investment by pharmaceutical companies in the anti-coronavirus drug discovery and development initiative is expected to further influence cloud-based solutions for drug discovery, development, and manufacturing.

Increasing investment in drug discovery, development, and manufacturing by pharmaceutical, biopharmaceutical, and other entities and the increasing adoption of cloud services for these activities are the major drivers of the market growth. The adoption of cloud-based services for drug discovery, development, and manufacturing is growing due to cloud technology's various advantages. For example, cloud-based services could help streamline operations and develop business cases to determine whether a drug is likely to be useful and financially viable or not. Also, according to a research study published by Olivier J. Wouters et al., in a March 2020 base case analysis, the median capitalized R&D investment to bring a new drug to market was estimated at $985.3 million, with an average investment of $1335.9 million and estimates varying across therapeutic areas, with cancer drug development costs being the highest. These high costs associated with the research and development of a new drug can be significantly reduced by deploying cloud services as it speeds up the drug discovery and development process and minimizes the chance of errors. Due to this factor, the adoption of cloud services in drug discovery, development, and marketing is increasing, which is expected to drive growth in the market under review over the forecast period. For example, in December 2021, Pfizer Inc. and Amazon Web Services (AWS) agreed to collaborate on the development of new cloud technologies that could revolutionize the way new drugs are researched, manufactured, and distributed for clinical trials.

Further, increasing investment in drug discovery and development with the increasing prevalence of various diseases is expected to positively impact the growth of the market under study. For example, according to a report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) in September 2021, biopharmaceutical companies invested more than a trillion dollars in research and development in the last decade alone, including a record year in 2020, when PhRMA member companies alone invested roughly 91 billion USD. Furthermore, according to the same source, more than 8,000 drugs were in development worldwide in 2021, with 74 percent potentially being first-in-class treatments or completely new ways to treat diseases. Due to heavy investments in the drug discovery and development initiative coupled with the benefits offered by cloud-based solutions, the adoption of cloud-based services in drug discovery, development, and manufacturing is expected to increase during the forecast period, fueling the growth of the studied market.

However, the high initial cost of implementation and deployment of cloud solutions and cybersecurity concerns are expected to restrain growth in the cloud-based solutions for drug discovery, development, and manufacturing market during the forecast period.

Cloud-based Solution for Drug Discovery Development & Manufacturing Industry Overview

The cloud-based solutions for drug discovery, development, and manufacturing market is fairly competitive with several global market players. With the technological advancements and funding, the new entrants in the market are expected to increase the competitive landscape in the studied market over the forecast period of the study. Some key players in the cloud-based solutions for drug discovery, development, and manufacturing market are International Business Machines (IBM) Corporation, Oracle, Amazon Web Services, Google, and Tata Consultancy Services, among others.

Cloud-based Solution for Drug Discovery Development & Manufacturing Market Leaders

  1. Amazon Web Services

  2. Accenture

  3. Tata Consultancy Services

  4. Oracle

  5. International Business Machines (IBM)

  6. *Disclaimer: Major Players sorted in no particular order
IBM, Amazon Web Services, Accenture,  Google, Oracle,  Veeva Systems, Tata Consultancy Services,  ArisGlobal, XtalPi, Nutanix, Alibaba Group, Cloud Pharmaceuticals Inc.
Need More Details on Market Players and Competiters?
Download PDF

Cloud-based Solution for Drug Discovery Development & Manufacturing Market News

  • In June 2022, Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, completed a USD 60 million Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
  • In January 2022, Excelra partnered for its Global Online Structure Activity Relationship Database (GOSTAR) with XtalPi Inc. to enhance its intelligent digital drug discovery and development platform.

Cloud-based Solution for Drug Discovery Development & Manufacturing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investment in the Drug Discovery, Development, and Manufacturing
    • 4.2.2 Rising Adoption of Cloud Technology in Drug Discovery, Development, and Manufacturing Market
    • 4.2.3 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Implementation and Deployment of Various Cloud Technologies
    • 4.3.2 Cybersecurity Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Service Type
    • 5.1.1 Software as a Service (SaaS)
    • 5.1.2 Platform as a Service (PaaS)
    • 5.1.3 Infrastructure as a Service (IaaS)
  • 5.2 By Cloud Type
    • 5.2.1 Public Cloud
    • 5.2.2 Private Cloud
    • 5.2.3 Hybrid Cloud
  • 5.3 By Application
    • 5.3.1 Drug Discovery & Development
    • 5.3.2 Drug Manufacturing
  • 5.4 By End User
    • 5.4.1 Biotechnology and Pharmaceutical Companies
    • 5.4.2 Contract Research Organizations (CRO)
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 IBM
    • 6.1.2 Amazon Web Services
    • 6.1.3 Accenture
    • 6.1.4 Google
    • 6.1.5 Oracle
    • 6.1.6 Veeva Systems
    • 6.1.7 Tata Consultancy Services
    • 6.1.8 ArisGlobal
    • 6.1.9 XtalPi
    • 6.1.10 Nutanix
    • 6.1.11 Alibaba Group
    • 6.1.12 Cloud Pharmaceuticals Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cloud-based Solution for Drug Discovery Development & Manufacturing Industry Segmentation

As per the scope of the report, the cloud is an umbrella term that refers to sharing computing resources and providing data to connected devices on demand. Users can allocate data mining and decision-making tasks more easily and cost-effectively using modern cloud-based systems, which offer decentralized/real-world data management and collaborative operational opportunities. The cloud-based solutions for drug discovery, development, and manufacturing market is segmented by service type (Software as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS)), by cloud type (public cloud, private cloud, and hybrid cloud), by end user (biotechnology and pharmaceutical companies, contract research organizations, and others) and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.

By Service Type Software as a Service (SaaS)
Platform as a Service (PaaS)
Infrastructure as a Service (IaaS)
By Cloud Type Public Cloud
Private Cloud
Hybrid Cloud
By Application Drug Discovery & Development
Drug Manufacturing
By End User Biotechnology and Pharmaceutical Companies
Contract Research Organizations (CRO)
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cloud-based Solution for Drug Discovery Development & Manufacturing Market Research FAQs

What is the current Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market size?

The Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market is projected to register a CAGR of 12.5% during the forecast period (2025-2030)

Who are the key players in Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market?

Amazon Web Services, Accenture, Tata Consultancy Services, Oracle and International Business Machines (IBM) are the major companies operating in the Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market.

Which is the fastest growing region in Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market?

In 2025, the North America accounts for the largest market share in Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market.

What years does this Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market cover?

The report covers the Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Industry Report

Statistics for the 2025 Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Report Snapshots